Gordy, J. T., Hui, Y., Schill, C., Wang, T., Chen, F., Fessler, K., . . . Markham, R. B. (2024). A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses. Frontiers Media S.A.
Chicago Style (17th ed.) CitationGordy, James Tristan, et al. A SARS-CoV-2 RBD Vaccine Fused to the Chemokine MIP-3α Elicits Sustained Murine Antibody Responses over 12 Months and Enhanced Lung T-cell Responses. Frontiers Media S.A, 2024.
MLA (9th ed.) CitationGordy, James Tristan, et al. A SARS-CoV-2 RBD Vaccine Fused to the Chemokine MIP-3α Elicits Sustained Murine Antibody Responses over 12 Months and Enhanced Lung T-cell Responses. Frontiers Media S.A, 2024.
Warning: These citations may not always be 100% accurate.